THE Therapeutic Goods Administration (TGA) has approved Kimmtrak (tebentafusp) to treat unresectable or metastatic uveal melanoma in HLA-A*02:01 positive patients.
The medication will remain on the Black Triangle Scheme for five years from the date the product is first supplied in Australia.
THE Pharmaceutical Society of Australia (PSA) has announced the launch of its 2026 national conference, PSA26, under the theme ‘Home of Pharmacists’, with registrations now open.
SLOWLY tapering off antidepressants, combined with psychological support, could help prevent depression relapse to a similar extent as remaining on antidepressants, according to a large review published in Lancet Psychiatry.
THE planned sale of Mayne Pharmaceuticals to US pharma company Cosette has been called off today, with Mayne providing Cosette with notice that it has terminated the scheme implementation deed due to Cosette’s breaches of the scheme.